Ahmad Paras, Estrin Nathan, Farshidfar Nima, Zhang Yufeng, Miron Richard J
Department of Research, Advanced PRF Education, Jupiter, Florida, USA.
Lake Erie College of Osteopathic Medicine School of Dental Medicine, Bradenton, Florida, USA.
Clin Oral Investig. 2025 Jun 25;29(7):357. doi: 10.1007/s00784-025-06422-1.
This review comprehensively examined the emerging role of exosomes derived from periodontal ligament stem cells (PDLSC-Exos) in regenerative medicine and dentistry, with a particular focus on their therapeutic potential in periodontitis-a prevalent inflammatory disease characterized by the progressive destruction of periodontal tissues.
An initial search on Scopus, Web of Science, and PubMed using terms associated with exosomes (i.e., exosomes, exosomal, extracellular vesicles, and EVs) and periodontal ligament stem cells without any limitation of publication year and field of study was performed on October 31st, 2024.
PDLSC-Exos demonstrated significant therapeutic efficacy in both bone and periodontal regeneration as well as various medical conditions through the enhancement of cellular proliferation, osteoblast differentiation, and the modulation of inflammatory responses. These exosomes function by regulating miRNA and activating essential signaling pathways, thereby facilitating periodontal/bone regeneration, angiogenesis, and tissue repair in disorders such as periodontitis, OTM, and skeletal bony defects. Furthermore, they exhibited anti-inflammatory properties, leading to improved outcomes under inflammatory conditions such as periodontitis, IBD, and MS. Moreover, PDLSC-Exos played a role in anti-microbial and anti-cancer interventions, demonstrating their diverse applicability.
The cell-free nature of these therapeutic agents makes PDLSC-Exos a versatile and promising tool for regenerative medicine and immune system regulation. The cell-free nature of these therapeutic agents positions PDLSC-Exos as a promising and adaptable instrument for regenerative medicine and immune system modulation.
PDLSC-Exos offer a promising acellular therapy for periodontal regeneration, overcoming limitations of cell-based approaches by enhancing tissue repair, modulating inflammation, and improving clinical translation in regenerative medicine and dentistry.
本综述全面研究了牙周膜干细胞来源的外泌体(PDLSC-Exos)在再生医学和牙科中的新兴作用,特别关注其在牙周炎(一种以牙周组织进行性破坏为特征的常见炎症性疾病)中的治疗潜力。
2024年10月31日,在Scopus、Web of Science和PubMed上进行了初步检索,使用了与外泌体相关的术语(即外泌体、外泌体的、细胞外囊泡和EVs)以及牙周膜干细胞,对发表年份和研究领域没有任何限制。
PDLSC-Exos通过增强细胞增殖、成骨细胞分化和调节炎症反应,在骨和牙周再生以及各种医学病症中显示出显著的治疗效果。这些外泌体通过调节miRNA和激活关键信号通路发挥作用,从而促进牙周/骨再生、血管生成以及在牙周炎、正畸牙移动(OTM)和骨骼骨缺损等疾病中的组织修复。此外,它们还表现出抗炎特性,在牙周炎、炎症性肠病(IBD)和多发性硬化症(MS)等炎症条件下导致更好的结果。此外,PDLSC-Exos在抗菌和抗癌干预中发挥作用,证明了它们的广泛适用性。
这些治疗剂的无细胞性质使PDLSC-Exos成为再生医学和免疫系统调节的通用且有前景的工具。这些治疗剂的无细胞性质使PDLSC-Exos成为再生医学和免疫系统调节的有前景且适应性强的工具。
PDLSC-Exos为牙周再生提供了一种有前景的无细胞疗法,通过增强组织修复、调节炎症以及改善再生医学和牙科中的临床转化,克服了基于细胞方法的局限性。